ISIS PHARMACEUTICAL INC has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are CROOKE ROSANNE M, GENEPOD THERAPEUTICS AB and KIDO TSUNEO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 1 | |
#5 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Electrical machinery and energy |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Enzymes | |
#5 | Climate change mitigation in goods production | |
#6 | Electric discharge tubes |
# | Name | Total Patents |
---|---|---|
#1 | Monia Brett P | 6 |
#2 | Cowsert Lex M | 4 |
#3 | Wancewicz Edward | 3 |
#4 | Swayze Eric E | 3 |
#5 | Seth Punit P | 3 |
#6 | Siwkowski Andrew M | 3 |
#7 | Bhanot Sanjay | 3 |
#8 | Mckay Robert | 3 |
#9 | Geary Richard S | 3 |
#10 | Marcusson Eric G | 2 |
Publication | Filing date | Title |
---|---|---|
AU2003273351A8 | Methods for blocking adipocyte differentiation and triglyceride accumulation with dual-specificity tyrosine- (y) - phosphorylation regulated kinase 4 (dyrk4) inhibitors | |
US6133032A | Antisense modulation of PI3 kinase p110 beta expression | |
US6124272A | Antisense modulation of PDK-1 expression |